[Toronto, Ontario, Canada] — June 9, 2026 — Wrango, the self-serve, platform-agnostic healthcare marketing platform, today announced its selection to the inaugural MM+M Agency 100 Partner Power List for 2026. Published by MM+M (Medical Marketing & Media) as part of its annual Agency 100 issue, the Partner Power List recognizes the technology and service partners making the most significant impact in pharmaceutical and healthcare marketing this year.
The recognition follows Wrango’s April 2026 public launch as a self-serve product. For more than a decade, modern HCP marketing has been gatekept by enterprise vendors with six-figure minimums, leaving smaller and mid-tier pharma brands locked out of the audience data, activation infrastructure, and outcomes-based measurement that the largest brands take for granted. Wrango’s launch removed those minimums, putting verified HCP targeting and prescription-level measurement within reach of brands of any size.
“Being named to the inaugural Partner Power List is meaningful recognition of what our team has built and the brands we serve,” said Josh Alvernia, CEO and Co-Founder of Wrango. “The larger story is what this kind of infrastructure does when it’s available to everyone and not just the top ten percent of pharma. When the cost floor for modern HCP marketing comes down, more brands can reach prescribers with precision, and more therapies reach the patients who need them. That is the work this recognition reflects.”
In the 18 months prior to its public launch, Wrango’s data and infrastructure powered campaigns for 35 pharmaceutical accounts, including Medtronic and several of the industry’s leading pharmaceutical brands. Many of these campaigns were also executed by leading healthcare agencies, such as Havas and CMI Media Group. The April 2026 launch productized that infrastructure into a self-serve interface available to brands and agencies of every size.
Wrango combines a consented identity graph of more than 4.6 million verified healthcare professionals, covering approximately 93% of actively practicing U.S. physicians across 852 specialties, with channel-agnostic activation across programmatic, search, and social, and closed-loop measurement against actual prescribing behavior. Brands can build a verified HCP audience, activate it on any major ad platform without a platform migration, and measure performance against real NRx and TRx data through a single self-serve interface with no minimums or upfront infrastructure cost.
The MM+M Agency 100 issue is the publication’s annual recognition of the agencies and partners shaping pharmaceutical and healthcare marketing. The full 2026 Agency 100 issue, including the Partner Power List, is available from MM+M.
About Wrango
Wrango is a healthcare marketing platform built to drive measurable outcomes. Powered by real-world claims and electronic health record data, Wrango enables pharmaceutical brands, agencies, and platforms to identify verified healthcare practitioners, activate them across any ad platform, and measure media impact against clinical behavior.
Wrango replaces slow, opaque healthcare marketing workflows with fast, self-serve tools. Its platform-agnostic architecture integrates directly into existing stacks, unlocking audience creation, activation, and closed-loop measurement without minimum spend requirements.
By making advanced audience intelligence and outcomes-based measurement accessible to teams of any size, Wrango helps healthcare marketers move faster, spend smarter, and prove real-world impact without compromising privacy or scale.